← Back to Search

Sensory Stimulation for Intellectual Disability

N/A
Recruiting
Led By Zenaide MN Quezado, M.D.
Research Sponsored by National Institutes of Health Clinical Center (CC)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Male or female, aged 8-30 years of age
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up end of study
Awards & highlights

Study Summary

This trial is comparing brain responses to unpleasant stimuli in people with and without intellectual disability.

Who is the study for?
This trial is for individuals aged 8 to 30 with intellectual disability (ID) and healthy volunteers without ID. Participants must speak English fluently, agree not to use certain medications or substances before the study, and be willing to follow all procedures. Pregnant women, those with neurological issues or a history of severe head injury are excluded.Check my eligibility
What is being tested?
The study tests how people with and without ID react to pain by using a TSA2 Thermosensory Stimulator. It involves one visit up to four hours long where brain activity in response to heat, cold, brushing, and mild electrical stimuli is measured.See study design
What are the potential side effects?
There may be temporary discomfort from the sensory tests such as heat or cold sensations and mild electrical stimulation during the trial. No significant side effects are expected from these non-invasive measurements.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 8 and 30 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~end of study
This trial's timeline: 3 weeks for screening, Varies for treatment, and end of study for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pain
Secondary outcome measures
Pain

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: 1/ID patientsExperimental Treatment1 Intervention
ID Patients
Group II: 2/Healthy controlsActive Control1 Intervention
Healthy controls

Find a Location

Who is running the clinical trial?

National Institutes of Health Clinical Center (CC)Lead Sponsor
383 Previous Clinical Trials
880,787 Total Patients Enrolled
Zenaide MN Quezado, M.D.Principal InvestigatorNational Institutes of Health Clinical Center (CC)

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Characterization of Nociception Phenotype in Individuals With Intellectual Disability
2024. "Characterization of Nociception Phenotype in Individuals With Intellectual Disability". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05473429.
~143 spots leftby Oct 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top